Horizon Discovery Group (HZD)

 

HZD Share PerformanceMore

52 week high188.05 29/04/16
52 week low104.00 30/11/16
52 week change -24.00 (-16.84%)
4 week volume3,071,191 08/11/16

Media for (HZD)

Presenter: Dr Darrin Disley
12/10/2014

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Director Deals - Horizon Discovery Group Plc (HZD)

Dr Susan Galbraith, Non Executive Director, bought 40,000 shares in the company on the 2nd December 2016 at a price of...

Director/PDMR Shareholding

RNS Number: 8359Q Horizon Discovery Group plc 02 December 2016 Horizon Discovery Group plc Director/PDMR Shareholding Cambridge, UK, 2 December 2016: Horizon Discovery Group plc (LSE: HZD) ("Horizon" or the "Company"), the world leader in the application of gene editing technologies , today announces that on 2 December 2016 Dr Susan Galbraith...

Director Dealings

RNS Number: 8194Q Horizon Discovery Group plc 02 December 2016 Horizon Discovery Group plc Director/PDMR Shareholding Cambridge, UK, 2 December 2016: Horizon Discovery Group plc (LSE: HZD) ("Horizon" or the "Company"), the world leader in the application of gene editing technologies , today announces that certain directors of the Company purcha...

Horizon enters Chinese clinical diagnostics market

Horizon Discovery Group has entered into partnerships with three leading Chinese diagnostic kit developers. Under the ter...

HZD Enters Chinese Clinical Diagnostics Market

RNS Number: 2032P Horizon Discovery Group plc 16 November 2016 Horizon Discovery Enters Chinese Clinical Diagnostics Market Three leading Chinese diagnostic kit manufacturers have initiated clinical trials using Horizon HDx Reference Standards Agreements provide upfront revenue with potential for strong recurring revenue streams post regulatory approv...

Additional Listing

RNS Number: 0218P Horizon Discovery Group plc 14 November 2016 14 November 2016 Horizon Discovery Group plc Additional Listing The Company has issued and allotted 5,554 new ordinary shares of 1p each pursuant to the exercise of options. Accordingly, an application has been made for 5,554 new ordinary shares to be admitted to trading on AIM and it is exp...

Horizon OEM agreement with CareDx

Horizon Discovery has entered into an original equipment manufacturer (OEM) agreement with CareDx, a molecular dia...

OEM Agreement with CareDx for Reference Standards

RNS Number: 6736O Horizon Discovery Group plc 09 November 2016 Horizon Discovery and CareDx Enter into OEM Agreement for Routine Inclusion of Cell-Free DNA Reference Standards in Transplant Testing Agreement builds on existing collaboration to develop cell-free DNA (cfDNA) Reference Standards to support CareDx's solid organ transplant injury m...

Fundamental DataMore

EPS-11.2
Dividend yield0 %

Latest discussion posts More

  • Numis

    From Citywire: "?Biologic? era benefits Horizon Discovery, says Numis Gene-editing company Horizon Discovery (HZDH) has improved efficiency and is driving its product ...
    20-Oct-2016
    nk1999
  • CPI partnership

    "An announcement this morning sees Horizon expand the application of its bioproduction cell line platform with new partnerships with the Centre for Process Innovation (CPI, UK) ...
    13-Sep-2016
    Sambram
  • QIAGEN

    Following Horizon's announcement on 12th of May of a deal with an NGS Company, we are now given the name of the Company - QIAGEN N.V. a US$5bn NASDAQ and Frankfurt listed ...
    2-Jun-2016
    Simbr

Users' HoldingsMore

Users who hold Horizon Discovery Group also hold..
GLAXOSMITHKLINE24%
LLOYDS GRP.23%
BP22%
BARCLAYS18%
RDS 'B'18%

Codes & Symbols

ISINGB00BK8FL363
SymbolsHZD, LSE:HZD, HZD.L, HZD:LN, LON:HZD, XLON:HZD